Reps. Engel, Guthrie Lead Over 90 House Members on Bipartisan Letter on Drug Shortages
September 16, 2019
September 16, 2019
WASHINGTON, Sept. 16 -- Rep. Eliot Engel, D-New York, issued the following news release:
U.S. Representatives Eliot L. Engel (D-NY) and Brett Guthrie (R-KY) led a group of 92 bipartisan lawmakers in a letter today to the Acting Commissioner of the Food and Drug Administration (FDA) Norman "Ned" Sharpless on the urgent issue of medical drug shortages.
Drug shortages of critical medicines such as epinephrine and ketamine can hinder the delivery of high-quality p . . .
U.S. Representatives Eliot L. Engel (D-NY) and Brett Guthrie (R-KY) led a group of 92 bipartisan lawmakers in a letter today to the Acting Commissioner of the Food and Drug Administration (FDA) Norman "Ned" Sharpless on the urgent issue of medical drug shortages.
Drug shortages of critical medicines such as epinephrine and ketamine can hinder the delivery of high-quality p . . .